Laboratory findings, as delineated in Table 1B, revealed salient disparities such as elevated NT-proBNP levels and a pronounced occurrence of selenium (Se) deficiency within the CF CMP cohort, though aggregate Se concentrations remained analogous across both patient groups. This evidence concerns the gene NPPB and cystic fibrosis.